Sudeep Pharma Limited (NSE: SUDEEPPHRM), ISIN INE0QPI01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUDEEPPHRM last traded at ₹867.35 (-1.30%), with a 52-week range of ₹524.95 to ₹907.40 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 76.15%, FIIs 1.81%, DIIs 15.65%, mutual funds 5.47%.
EquiSense Score (ECS): 90/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.